VistaGen Wins NIH Funding 

South San Francisco-based VistaGen Therapeutics, Inc., a biopharmaceutical firm specializing in the use of embryonic stem cell technologies in drug development, was awarded a $1.2 million grant from National Institutes of Health, the company announced Tuesday.

The funding is the final phrase of a $4.3 grant for the development of AV-101, a potential treatment for neuropathic pain, Parkinson’s disease and epilepsy.

About The Author

Staff Report

Staff Report

Bio:
A daily newspaper covering San Francisco, San Mateo County and serving Alameda, Marin and Santa Clara counties.
Pin It
Favorite

Speaking of Business

More by Staff Report

Latest in Business & Real Estate

© 2018 The San Francisco Examiner

Website powered by Foundation